- I39 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM I39 became effective on October 1, 2022.
- This is the American ICD-10-CM version of I39 – other international versions of ICD-10 I39 may differ.
ICD-10-CM I39 is grouped within Diagnostic Related Group(s):
- 306 Cardiac congenital and valvular disorders with mcc
- 307 Cardiac congenital and valvular disorders without mcc
- 791 Prematurity with major problems
- 793 Full term neonate with major problems
Type 1 Excludes
- endocardial involvement in:
- candidiasis (B37.6)
- gonococcal infection (A54.83)
- Libman-Sacks disease (M32.11)
- listerosis (A32.82)
- meningococcal infection (A39.51)
- rheumatoid arthritis (M05.31)
- syphilis (A52.03)
- tuberculosis (A18.84)
- typhoid fever (A01.02)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to I39: